Abstract
I believe that the Helen F. Graham Cancer Center program development along with statewide cancer control has transformed Delaware. Cancer mortality rates and the adult smoking rate in the state are dropping twice as fast as the national average. Cancer incidence is declining among African-Americans three times faster than among Caucasians. The Center for Translational Cancer Research and the Tissue Procurement Center have allowed clinicians at the Helen F. Graham Cancer Center and scientists to work together and receive NIH grants. Importantly, NIH funding to Delaware grew six-fold from $5 million in 1995 to $30 million in 2008. The NCCCP has expanded the Helen F. Graham Cancer Center Outreach to underserved areas, increased minority recruitment to clinical trials and led to funding for the Cancer Genome Atlas Project. The Helen F. Graham Cancer Center Outreach Program together with the state cancer control programs have resulted in Delaware being third in the United States for women who have received a mammogram in the last two years, third for women who have received a pap smear in the last three years, and first for individuals who have received a colonoscopy/sigmoidoscopy in the last five years. The High Risk Family Cancer Registry, the multidisciplinary disease site centers, our Cancer Outreach Program, the NCI clinical trials, and Center for Translational Cancer Research are the strong foundation to build on for the Cancer Program in the next five years.
Accepted Version (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call